What does Checkpoint Capital L.P. hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Comprehensive Analysis of Checkpoint Capital L.P. 13F Filing (Q3 2025)

1. Portfolio Overview

Checkpoint Capital L.P. manages a highly concentrated, specialized investment portfolio totaling approximately $233.96 million as of September 30, 2025. The firm demonstrates a distinct "high-conviction" strategy, evidenced by the extremely low number of holdings (7) and the significant allocation weighting to top positions.

The portfolio experienced robust growth during the quarter, increasing i...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

ARGX

ARGENX SE

$112M153K40.1%

RYTM

RHYTHM PHARMACEUTICALS INC

$107M1.2M38.3%

RVMD

REVOLUTION MEDICINES INC

$26M263K9.2%

IRON

DISC MEDICINE INC

$18M287K6.6%

CYTK

CYTOKINETICS INC

$12M180K4.3%

SEPN

SEPTERNA INC

$2M100K0.9%

CRNX

CRINETICS PHARMACEUTICALS IN

$1M40K0.5%

TRVI

TREVI THERAPEUTICS INC

$596,50050K0.2%

Filing history

Filing history loading…